• Goldman Sachs lifted its total voting rights stake in Carl Zeiss Meditec to 5.7% from 5.02%.
• Holdings via instruments rose to 5.01% from 4.48%, led by swaps, call options, call warrants, right to recall, right of use.
• Voting rights attached to shares increased to 0.68% from 0.54%.
• The threshold was crossed on Sept. 29, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carl Zeiss Meditec AG published the original content used to generate this news brief via EQS News (Ref. ID: PVR_2410806_en) on October 06, 2026, and is solely responsible for the information contained therein.